Anastrozole - Solicitation
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-25-R-0007
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Defense Logistics Agency (DLA) Troop Support has issued a formal solicitation, identified as SPE2D2-25-R-0007, for the procurement of Anastrozole, a pharmaceutical product. This opportunity is classified under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further designated by Product Service Code 6505, indicating a focus on drugs and biologicals. The solicitation is currently active and available for review, with all relevant documentation accessible via the provided SAM.gov link.
The primary objective of this procurement is to secure a reliable supply of Anastrozole, a medication commonly used in the treatment of certain types of breast cancer. The scope of the contract will likely encompass the manufacturing, packaging, and delivery of Anastrozole in accordance with federal standards and DLA Troop Support requirements. While the specific quantities, packaging specifications, and delivery schedules are detailed in the attached solicitation document, contractors should anticipate strict adherence to pharmaceutical quality and regulatory compliance throughout the contract lifecycle.
DLA Troop Support, a federal office responsible for providing medical and pharmaceutical supplies to military and federal agencies, is the contracting entity for this solicitation. The agency is seeking qualified manufacturers with proven capabilities in pharmaceutical preparation and distribution. Interested parties are encouraged to review the solicitation in detail to ensure alignment with their production capacities, regulatory certifications, and quality assurance protocols.
The procurement is structured as a solicitation, inviting competitive proposals from eligible contractors. There is no explicit mention of set-aside requirements or special considerations such as small business preferences in the provided information; prospective bidders should consult the attached solicitation for any such stipulations.
Key contacts for this opportunity include Nancy Fernandez ([email protected], 215-737-4955) and Jason Wray ([email protected], 215-737-0614), who can provide additional information or clarification regarding the solicitation process.
The solicitation was posted on December 3, 2025, and responses are due by November 4, 2025, at 07:04. Contractors interested in pursuing this opportunity should review the full solicitation document, available through the SAM.gov portal, to ensure a comprehensive understanding of all requirements, submission instructions, and evaluation criteria.
This procurement represents a significant opportunity for pharmaceutical manufacturers with the capability to meet federal supply standards for Anastrozole, and it underscores DLA Troop Support’s ongoing commitment to maintaining a robust and reliable supply chain for critical medical products.